Physician profile
Amy Franklin
NPI 1659048494
$412.34
in general payments reported to CMS, 2019-2025
11 companies · $15.80 in 2025
The $15.80 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $70.07 · 2022: $93.09 · 2023: $150 · 2024: $83.60 · 2025: $15.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $149 · Consulting Fee: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.18 |
| Consulting Fee | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guard Medical INC. | $100.00 | 2023 | Npseal (5), Npseal Medium, Npseal Large |
| Novo Nordisk INC | $66.52 | 2021-2025 | Ozempic, Rybelsus |
| Amgen INC. | $44.99 | 2021-2022 | |
| Lilly USA, LLC | $44.79 | 2022-2024 | Mounjaro, Zepbound |
| Xeris Pharmaceuticals, INC. | $39.63 | 2023-2024 | Gvoke Hypopen |
| Abbvie INC. | $28.98 | 2022-2023 | |
| Insulet Corporation | $21.29 | 2023 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $19.80 | 2024 | |
| Sanofi-Aventis U.S. LLC | $17.44 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.78 | 2021 | |
| Organon LLC | $14.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.